This is a non-core endpoint: only basic statistics are computed.
Lung cancer and mesothelioma
LUNG_CANCER_MESOT
No definition available.
Endpoint definition
↥392423 individuals
Apply sex-specific rule None
392423
Check conditions None
392423
Check pre-conditions, main-only, mode, registry filters
3 out of 7 registries used, show all original rules.
7844
Check minimum number of events None
7844
Include endpoints None
7844
Remove individuals based on genotype QC
7600
Control definitions
Extra metadata
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to Lung cancer and mesothelioma based on the number of shared cases.
Broader endpoints:
- Rheumatoid arthritis-related co-morbidities
- Excluding asthma or asthma-COPD overlap
- COPD differential diagnosis
- ILD differential diagnosis
- Rheumatological diseases related comorbidities
Narrower endpoints:
Summary Statistics
↥Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | 7600 | 1880 | 5720 |
Unadjusted prevalence (%) | 2.02 | 0.89 | 3.44 |
Mean age at first event (years) | 70.76 | 67.46 | 71.85 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: LUNG_CANCER_MESOT – Lung cancer and mesothelioma
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Lung cancer and mesothelioma
↥Endpoint not on priority list, no data to show.